MedTrace Logo

The Impact of a Human Breast Milk Supplement on Epigenetic and Cellular Markers

NCT05297097 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2022-09-08

No results posted yet for this study

Summary

This is a trial to assess the effects of the Trulacta supplement on biological age, sleep quality, immune system and wellness markers.

Conditions

  • Aging

Interventions

DIETARY_SUPPLEMENT

Trulacta breastmilk supplement

one supplement daily

Sponsors & Collaborators

  • Adventa Biosciences

    collaborator UNKNOWN

  • TruDiagnostic

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-03-01
Primary Completion
2022-12-01
Completion
2022-12-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05297097 on ClinicalTrials.gov